Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 4/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.31 |
| ▸ | TACR3 | P29371 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20908295 | 1.00 | MEN1 (0.32) | MEN1KMT2AELANEAAK1TACR3 | |
| SCHEMBL29640278 | 1.00 | MEN1 (0.32) | MEN1KMT2AELANEAAK1TACR3 | |
| SCHEMBL20908290 | 0.93 | ELANE (0.30) | ELANE | |
| SCHEMBL21112505 | 0.93 | TACR3 (0.33) | MEN1KMT2AELANEAAK1TACR3 | |
| SCHEMBL21112509 | 0.93 | TACR3 (0.33) | MEN1KMT2AELANEAAK1TACR3 | |
| SCHEMBL29640279 | 0.83 | MEN1 (0.37) | MEN1KMT2AAAK1CTSSSCN9A | |
| SCHEMBL21149567 | 0.83 | MEN1 (0.37) | MEN1KMT2AAAK1CTSSSCN9A | |
| SCHEMBL20907698 | 0.83 | MEN1 (0.37) | MEN1KMT2AAAK1CTSSSCN9A | |
| SCHEMBL20907560 | 0.82 | MEN1 (0.37) | MEN1KMT2AAAK1CTSSSCN9A | |
| SCHEMBL28407708 | 0.82 | MEN1 (0.37) | MEN1KMT2AAAK1CTSSSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111212832-A | 1-benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as HIV protease inhibitors | 吉利德科学公司 | 2020-05-29 | — | — | CN | disclosed |